# China NMPA Product Recall - MynxGrip Vascular Closure Devices

Source: https://www.keypedia.com/records/china_product_recall/cardinal-health-200-llc/cb36e82d-8bcf-45f7-a2ee-a1361fad81d8
Source feed: China

> China NMPA product recall for MynxGrip Vascular Closure Devices by Cardinal Health 200, LLC published January 23, 2024. Recall level: Level 2 Recall. The National Medical Products Administration (NMPA) issued a notice on January 23, 2024, detailing a

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Cardinal Health is proactively recalling its occlusion hemostasis system.
- Company Name: Cardinal Health 200, LLC
- Publication Date: 2024-01-23
- Product Name: MynxGrip Vascular Closure Devices
- Recall Level: Level 2 Recall
- Recall Reason: The product in question had incorrect label information on its outer box.
- Discovering Company: Contis (Shanghai) Medical Devices Co., Ltd.
- Manufacturing Company: Cardinal Health 200, LLC
- Summary: The National Medical Products Administration (NMPA) issued a notice on January 23, 2024, detailing a voluntary Class II recall initiated by Cardinal Health. The manufacturer, Cardinal Health, along with Cardinal Health (Shanghai) Medical Devices Co., Ltd., is recalling its MynxGrip Vascular Cl Devices, which are registered under National Medical Device Registration Certificate No. 20233130334. The primary issue identified is incorrect labeling information found on the outer packaging of the affected product. This regulatory action falls under the NMPA's oversight, with the Class II designation indicating that while the issue is not immediately life-threatening, it could potentially cause temporary or reversible adverse health consequences. In response to this non-compliance, Cardinal Health has undertaken a voluntary recall to correct the identified discrepancy. Specific details regarding the models, specifications, and batch numbers of the affected devices are provided in the "Medical Device Recall Event Report Form" associated with this announcement. The company's proactive measure aims to ensure product integrity and adherence to regulatory standards for medical device labeling.

Company: https://www.keypedia.com/companies/cardinal-health-200-llc/cd49e77f-bfac-4de1-b08b-e002319a5544